Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients

NCT03344627 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Sepsis
Septic Shock
Critical Illness
Carbapenem
Pharmacokinetic
Pharmacodynamic
Clinical Outcome
Organ Failure, Multiple
Morality

Interventions

DRUG: Meropenem standard dose
DRUG: Meropenem high dose

Sponsor

Mahidol University